Drug · DIN 02017776
PRIMAQUINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 26, 2009; first marketed December 31, 1945.
- Drug Identification Number (DIN)
- 02017776
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Primaquine P01BA03
- Class
- Human
- Record last updated
- June 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PRIMAQUINE PHOSPHATE | 26.3 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 30, 2006: NOC 7991New Drug Submission (NDS) · Manufacturer name change
- April 2, 2001: NOC 2527New Drug Submission (NDS) · Manufacturer name change